eli lilly zepbound tirzepatide Finds Yet Another Condition for to Treat. The Stock Is Up Lilly releases Zepbound® (tirzepatide) single-dose

8 Compared with placebo, once weekly tirzepatide significantly reduced the combined risk of cardiovascular death or worsening HF events (hospitalisation or an urgent hospital visit requiring intravenous therapy)

However, the underlying biochemistry of the tirzepatide molecule remains the same

Mechanism of Action Tirzepatide acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors

Refined Carbohydrates and Sugary Foods to Skip Refined carbohydrateswhite bread, pastries, sugary drinks, and processed snacksspike blood glucose rapidly and provide minimal satiety on GLP-1 therapy